Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No
- PMID: 17494018
- PMCID: PMC1867901
- DOI: 10.1136/bmj.39202.397488.AD
Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No
Abstract
Women in western countries are more likely to die from heart disease than from cancer. Scott M Grundy argues that the risks make preventive treatment essential, but Malcolm Kendrick believes the evidence of benefit is not strong enough
Conflict of interest statement
Comment on
-
Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes.BMJ. 2007 May 12;334(7601):982. doi: 10.1136/bmj.39202.399942.AD. BMJ. 2007. PMID: 17494017 Free PMC article.
References
-
- Miettinen TA, Pyorala K, Olsson AG, Musliner TA, Cook TJ, Faergeman O, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian simvastatin survival study (4S). Circulation 1997;96:4124-5. - PubMed
-
- Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA 2004;291:2243-52. - PubMed
-
- Draeger A, Monastyrskaya K, Mohaupt M, Hoppeler H, Savolainen H, Allemann C. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol 2006;210:94-102. - PubMed
-
- Stepper HD. Letter in response (F04-172). Rockville, MD: Public Health Service Center for Drug Evaluation and Research Office of Regulatory Policy, Division of Information Disclosure Policy, 2004.
-
- Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994;334:1383-9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources